http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011139369-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ed9941bee6d598124a916ac0bd85ca56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1e62a5bf5c3a0cb76586eafff9f94f91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8299881a96b452b4fb1c664c2519c9ac
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-22
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00
filingDate 2011-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e04b26bcf1d8544316f20ae31a02d8c2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bba4a0b0f3c306349d7c8ffee74ee183
publicationDate 2011-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2011139369-A1
titleOfInvention Method of functionalizing human red blood cells with antibody
abstract The present invention relates to producing more densely functionalized indicator cells which along, with other components, can be used to detect the presence or absence of antibodies or antigens, by using the A, B, AB and MNS antigens which have a greater degree of expression than the conventionally used D antigen to label the indicator cells with IgG. The present antigen systems have levels of expression that approach one million antigens per cell, which is in great contrast to the conventional D antigen sites of about 10,000-30,000 antigens per cell. This marked increase in the antigen systems level of expression could produce a boost in the kinetics and the magnitude of the binding of the indicator cell to the solid phase, which improves assay performance.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10156574-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2991679-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017089827-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10883997-B2
priorityDate 2010-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009074749-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4816413-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5213963-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID119065
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399539
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6235
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226530007

Total number of triples: 27.